InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $1.150 0.05 (4.17%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$36 Appendix 3Y - Dr Chris Roberts 18 May 2018 9:49AM $0.155 $1.150 risen by 641.94%
$36 Appendix 3Y - Dr Martin Cross 18 May 2018 9:48AM $0.155 $1.150 risen by 641.94%
$36 Appendix 3B 17 May 2018 3:34PM $0.155 $1.150 risen by 641.94%
$36 Results of Extraordinary General Meeting 2018 14 May 2018 12:40PM $0.160 $1.150 risen by 618.75%
$36 Oncosil submits Clinical Study Report to Notified Body 14 May 2018 9:02AM $0.165 $1.150 risen by 596.97%
$36 OSL to present at Finance News Network Investor Session 2 May 2018 9:09AM $0.132 $1.150 risen by 771.21%
$36 Appendix 3Y - Dr Martin Cross Share Purchase Plan 26 Apr 2018 4:17PM $0.135 $1.150 risen by 751.85%
$36 Appendix 3Y - Daniel Kenny Share Purchase Plan 26 Apr 2018 4:16PM $0.135 $1.150 risen by 751.85%
$36 Appendix 3Y - Dr Chris Roberts Share Purchase Plan 26 Apr 2018 4:14PM $0.135 $1.150 risen by 751.85%
$36 Appendix 4C & Quarterly Update 26 Apr 2018 10:15AM $0.135 $1.150 risen by 751.85%
$36 Appendix 3B - Share Purchase Plan 20 Apr 2018 12:18PM $0.140 $1.150 risen by 721.43%
$36 ASIC Form 484 20 Apr 2018 8:41AM $0.140 $1.150 risen by 721.43%
$36 OncoSil Medical raises $4.0m from Share Purchase Plan 19 Apr 2018 10:06AM $0.140 $1.150 risen by 721.43%
$36 EGM Notice of Meeting & Proxy Form 13 Apr 2018 12:26PM $0.135 $1.150 risen by 751.85%
$36 Oncosil Medical Share Purchase Plan Closing Date Reminder 11 Apr 2018 4:09PM $0.135 $1.150 risen by 751.85%
$36 Oncosil Medical presents at Proactive Investors CEO Sessions 9 Apr 2018 9:02AM $0.125 $1.150 risen by 820%
$36 Clinical Programme Update 4 Apr 2018 9:45AM $0.120 $1.150 risen by 858.33%
$36 Change in substantial holding 3 Apr 2018 5:12PM $0.120 $1.150 risen by 858.33%
$36 CEO Interview - Clinical data update and outlook video 3 Apr 2018 1:55PM $0.130 $1.150 risen by 784.62%
$36 Ceasing to be a substantial holder for OSL 28 Mar 2018 12:20PM $0.130 $1.150 risen by 784.62%
$36 Oncosil Medical Share Purchase Plan 28 Mar 2018 9:56AM $0.135 $1.150 risen by 751.85%
$36 Cleansing Statement & Appendix 3B 28 Mar 2018 9:29AM $0.135 $1.150 risen by 751.85%
$36 Successful Completion of Capital Raising 22 Mar 2018 12:10PM $0.140 $1.150 risen by 721.43%
$36 Presentation-Surgical Resection Outcomes and Capital Raising 21 Mar 2018 9:44AM $0.140 $1.150 risen by 721.43%
$36 Surgical Resection Outcomes and Capital Raising 21 Mar 2018 9:39AM $0.140 $1.150 risen by 721.43%

601 - 625 of 794 results

Page 25 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.